Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide.

[1]  H. Baumgartner,et al.  Natriuretic Peptides Predict Symptom-Free Survival and Postoperative Outcome in Severe Aortic Stenosis , 2004, Circulation.

[2]  H. Scheld,et al.  A-Type and B-Type Natriuretic Peptides in Cardiac Surgical Procedures , 2004, Anesthesia and analgesia.

[3]  C. Tribouilloy,et al.  Low‐Gradient Aortic Stenosis Operative Risk Stratification and Predictors for Long‐Term Outcome: A Multicenter Study Using Dobutamine Stress Hemodynamics , 2003, Circulation.

[4]  Philippe Ravaud,et al.  A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. , 2003, European heart journal.

[5]  H. White,et al.  Increased Plasma Natriuretic Peptide Levels Reflect Symptom Onset in Aortic Stenosis , 2003, Circulation.

[6]  G. Habib,et al.  Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. , 2002, Circulation.

[7]  R. Hall,et al.  Recommendations on the management of the asymptomatic patient with valvular heart disease. , 2002, European heart journal.

[8]  Alan S Maisel,et al.  Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. , 2002, The New England journal of medicine.

[9]  R. Berger,et al.  B-Type Natriuretic Peptide Predicts Sudden Death in Patients With Chronic Heart Failure , 2002, Circulation.

[10]  A. DeMaria,et al.  Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: Comparison With Doppler Velocity Recordings , 2002, Circulation.

[11]  P. Mathisen,et al.  Natriuretic peptides in patients with aortic stenosis. , 2001, American heart journal.

[12]  N. Tamura,et al.  Brain natriuretic peptide appears to act locally as an antifibrotic factor in the heart. , 2001, Canadian journal of physiology and pharmacology.

[13]  E. DeLong,et al.  Prediction of operative mortality after valve replacement surgery. , 2001, Journal of the American College of Cardiology.

[14]  L. Lenert,et al.  Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. , 2001, Journal of the American College of Cardiology.

[15]  M. Schemper,et al.  Predictors of outcome in severe, asymptomatic aortic stenosis. , 2000, The New England journal of medicine.

[16]  Kenji Nakamura,et al.  Cardiac fibrosis in mice lacking brain natriuretic peptide. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Yoshikawa,et al.  Effect of angiotensin-converting enzyme inhibitor on left ventricular parameters and circulating brain natriuretic peptide in elderly hypertensives with left venticular hypertrophy. , 2000, Metabolism: clinical and experimental.

[18]  C. Frampton,et al.  Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. , 1998, Circulation.

[19]  R. Gibbons,et al.  ACC/AHA Guidelines for the Management of Patients With Valvular Heart Disease. Executive Summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). , 1998, The Journal of heart valve disease.

[20]  O. K. Hansen,et al.  Left ventricular systolic and diastolic function in aortic stenosis. Prognostic value after valve replacement and underlying mechanisms. , 1997, European heart journal.

[21]  H. Itoh,et al.  Plasma levels of brain and atrial natriuretic peptides elevate in proportion to left ventricular end-systolic wall stress in patients with aortic stenosis. , 1997, American heart journal.

[22]  K. Inouye,et al.  Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. , 1991, The Journal of clinical investigation.

[23]  K. Nakao,et al.  Biosynthesis, secretion, and receptor selectivity of human brain natriuretic peptide. , 1991, Canadian journal of physiology and pharmacology.

[24]  D. Horstkotte,et al.  The natural history of aortic valve stenosis. , 1988, European heart journal.

[25]  L Hatle,et al.  DIAGNOSTIC METHODS , 2005 .

[26]  J. Seward,et al.  Continuous-wave Doppler echocardiographic assessment of severity of calcific aortic stenosis: a simultaneous Doppler-catheter correlative study in 100 adult patients. , 1985, Circulation.

[27]  J. Seward,et al.  Doppler echocardiography: theory, instrumentation, technique, and application. , 1985, Mayo Clinic proceedings.